| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cardioprotective role of ischemic postconditioning in acute myocardial infarction: A systematic review and meta-analysis
|
Khan, Abdur Rahman
|
|
2014
|
168 |
4 |
p. 512-521.e4
5.209489E6 p.
|
artikel
|
| 2 |
Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus
|
Harskamp, Ralf E.
|
|
2014
|
168 |
4 |
p. 471-478
8 p.
|
artikel
|
| 3 |
Correction
|
|
|
2014
|
168 |
4 |
p. 605-
1 p.
|
artikel
|
| 4 |
Design and rationale of the ANALYZE ST study: A prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients
|
Gibson, C. Michael
|
|
2014
|
168 |
4 |
p. 424-429.e1
3867 p.
|
artikel
|
| 5 |
Development of a data set of national cardiovascular deaths in the young
|
Vetter, Victoria L.
|
|
2014
|
168 |
4 |
p. 568-576.e19
5.76E21 p.
|
artikel
|
| 6 |
Differences in sex-related bleeding and outcomes after percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry
|
Othman, Hussein
|
|
2014
|
168 |
4 |
p. 552-559
8 p.
|
artikel
|
| 7 |
Does baseline hematocrit influence the assays of on-treatment platelet reactivity to clopidogrel?
|
Pendyala, Lakshmana K.
|
|
2014
|
168 |
4 |
p. 545-551
7 p.
|
artikel
|
| 8 |
Dual antiplatelet therapy in patients with stable coronary artery disease in modern practice: Prevalence, correlates, and impact on prognosis (from the Suivi d’une cohorte de patients COROnariens stables en region NORd-Pas-de-Calais study)
|
Lemesle, Gilles
|
|
2014
|
168 |
4 |
p. 479-486
8 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2014
|
168 |
4 |
p. A4-
1 p.
|
artikel
|
| 10 |
Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c
|
Arnold, Suzanne V.
|
|
2014
|
168 |
4 |
p. 457-465.e2
46044 p.
|
artikel
|
| 11 |
Finding atrial fibrillation in stroke patients: Randomized evaluation of enhanced and prolonged Holter monitoring—Find-AFRANDOMISED —rationale and design
|
Weber-Krüger, Mark
|
|
2014
|
168 |
4 |
p. 438-445.e1
4013 p.
|
artikel
|
| 12 |
Impact of an invasive strategy on 5 years outcome in men and women with non–ST-segment elevation acute coronary syndromes
|
Alfredsson, Joakim
|
|
2014
|
168 |
4 |
p. 522-529
8 p.
|
artikel
|
| 13 |
Information for Readers
|
|
|
2014
|
168 |
4 |
p. A5-
1 p.
|
artikel
|
| 14 |
Letter to the editor regarding manuscript “Resuscitation Outcomes Consortium–Amiodarone, Lidocaine or Placebo: Rationale and methodology behind out-of-hospital cardiac arrest antiarrhythmic drug trial”
|
Iannone, Primiano
|
|
2014
|
168 |
4 |
p. e17-
1 p.
|
artikel
|
| 15 |
Mortality after presentation with stent thrombosis is associated with time from index percutaneous coronary intervention: A report from the VA CART program
|
Armstrong, Ehrin J.
|
|
2014
|
168 |
4 |
p. 560-567
8 p.
|
artikel
|
| 16 |
PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: Results of two 6-month, phase 3 studies
|
Whellan, David J.
|
|
2014
|
168 |
4 |
p. 495-502.e4
5.019506E6 p.
|
artikel
|
| 17 |
Physical activity and resting pulse rate in older adults: Findings from a randomized controlled trial
|
O’Hartaigh, Bríain
|
|
2014
|
168 |
4 |
p. 597-604
8 p.
|
artikel
|
| 18 |
Platelet reactivity during ticagrelor maintenance therapy: A patient-level data meta-analysis
|
Alexopoulos, Dimitrios
|
|
2014
|
168 |
4 |
p. 530-536
7 p.
|
artikel
|
| 19 |
Prevalence of glucose abnormalities among patients presenting with an acute myocardial infarction
|
Arnold, Suzanne V.
|
|
2014
|
168 |
4 |
p. 466-470.e1
4235 p.
|
artikel
|
| 20 |
Prognostic implications of creatine kinase–MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention
|
Bagai, Akshay
|
|
2014
|
168 |
4 |
p. 503-511.e2
50598 p.
|
artikel
|
| 21 |
Rationale and design of the MONITOR-ICD study: A randomized comparison of economic and clinical effects of automatic remote MONITORing versus control in patients with Implantable Cardioverter Defibrillators
|
Zabel, Markus
|
|
2014
|
168 |
4 |
p. 430-437
8 p.
|
artikel
|
| 22 |
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
|
O’Brien, Emily C.
|
|
2014
|
168 |
4 |
p. 487-494
8 p.
|
artikel
|
| 23 |
Regarding manuscript: “Resuscitation Outcomes Consortium–Amiodarone, Lidocaine, or Placebo study: Rationale and methodology behind out-of-hospital cardiac arrest antiarrhythmic drug trial”
|
Kudenchuk, Peter J.
|
|
2014
|
168 |
4 |
p. e19-e20
nvt p.
|
artikel
|
| 24 |
Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin
|
Baker, Nevin C.
|
|
2014
|
168 |
4 |
p. 537-544
8 p.
|
artikel
|
| 25 |
Table of Contents
|
|
|
2014
|
168 |
4 |
p. A1-A3
nvt p.
|
artikel
|
| 26 |
The effect of indapamide versus hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: Results of a randomized trial
|
Vinereanu, Dragos
|
|
2014
|
168 |
4 |
p. 446-456
11 p.
|
artikel
|
| 27 |
The fibrosis biomarkers procollagen type III, N-terminal propeptide and transforming growth factor β1 as foes for patients with atrial fibrillation
|
Tao, Hui
|
|
2014
|
168 |
4 |
p. e15-
1 p.
|
artikel
|
| 28 |
The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: The FRIENDS registry
|
Duval, Sue
|
|
2014
|
168 |
4 |
p. 577-587
11 p.
|
artikel
|
| 29 |
Transcatheter aortic valve replacement: Historical perspectives, current evidence, and future directions
|
Horne Jr., Aaron
|
|
2014
|
168 |
4 |
p. 414-423
10 p.
|
artikel
|
| 30 |
Unique device identifiers for coronary stent postmarket surveillance and research: A report from the Food and Drug Administration Medical Device Epidemiology Network Unique Device Identifier Demonstration
|
Tcheng, James E.
|
|
2014
|
168 |
4 |
p. 405-413.e2
40896 p.
|
artikel
|
| 31 |
Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)
|
Jones, William Schuyler
|
|
2014
|
168 |
4 |
p. 588-596
9 p.
|
artikel
|
Tijdschrift beschrijving